It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile

-or-

call (888) 352-RUSH for help arranging an appointment

Joshua Melson, MD, MPH

Specialty:
  • Gastroenterology
  • Internal Medicine
Board Certification:
  • Gastroenterology
  • Internal Medicine
Faculty Rank: Assistant Professor
Medical or Graduate Education: Indiana University School of Medicine
Residency: Rush University Medical Center - Internal Medicine
Fellowship: Rush University Medical Center - Gastroenterology
Clinical Expertise:
  • Barrett's esophagus
  • Cancer prevention and screening
  • Carcinoid tumor
  • Colonoscopy
  • Colorectal cancer
  • Enteroscopy
  • Enteroscopy, single balloon
  • Esophagogastroduodenoscopy (EGD)
  • Familial adenomatous polyposis (FAP)
  • Gastrointestinal cancers
Research Interests:
  • Barrett's esophagus
  • Hereditary colon cancer
  • Colon cancer screening
Google Map
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J, Li Y, Cassinotti E, Melnikov A, Boni L, Ai J, Greenspan M, Mobarhan S, Levenson V, Deng Y
    Int. J. Cancer
    2014 Jun 1
    134(11):2656-62.
  2. Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multi-ethnic study.
    Xicola R, Gagnon M, Clark JR, Carroll T, Gao W, Fernandez C, Mijic D, Rawson JB, Janoski A, Pusatcioglu CK, Rajaram P, Gluskin A, Regan M, Chaudhry V, Abcarian H, Blumetti J, Cintron J, Melson JE, Xie H, Guzman G, Emmadi R, Angelova V, Kupfer SS, Braunchweig C, Ellis NA, Llor X
    Clin. Cancer Res.
    2014 Jul 10
  3. Advanced Adenoma Detection Rate Is Independent of Nonadvanced Adenoma Detection Rate.
    Greenspan M, Rajan KB, Baig A, Beck T, Mobarhan S, Melson J.
    Am J Gastroenterol. 2013
    2013 May 28. doi: 10.1038/ajg.2013.149. [Epub ahead of print]
  4. Endoscopic mis-sizing of polyps changes colorectal cancer surveillance recommendations.
    Eichenseer PJ, Dhanekula R, Jakate S, Mobarhan S, Melson JE.
    Dis Colon Rectum. 2013
    2013 Mar
    56(3):315-21. doi: 10.1097/DCR.0b013e31826dd138.
  5. PI3K/AKT Signaling Is Essential for Communication between Tissue-Infiltrating Mast Cells, Macrophages, and Epithelial Cells in Colitis-Induced Cancer.
    Khan MW, Keshavarzian A, Gounaris E, Melson JE, Cheon EC, Blatner NR, Chen ZE, Tsai FN, Lee G, Ryu H, Barrett TA, Bentrem DJ, Beckhove P, Khazaie K.
    Clin Cancer Res. 2013
    2013 Apr 12. [Epub ahead of print]
  6. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
    Cassinotti E, Melson J, Liggett T, Melnikov A, Yi Q, Replogle C, Mobarhan S, Boni L, Segato S, Levenson V.
    Int J Cancer. 2012
    2012 Sep 1
    131(5):1153-7. doi: 10.1002/ijc.26484. Epub 2011 Nov 19.
  7. Histopathology predictors of medically refractory ulcerative colitis.
    Melson JE, Giusto D, Kwasny M, Eichenseer P, Jakate S, Keshavarzian A.
    Dis Colon Rectum. 2010
    2010 Sep
    53(9):1280-6. doi: 10.1007/DCR.0b013e3181e751df.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript